Amgen, Inc. (AMGN)
345.08
-0.64
(-0.19%)
USD |
NASDAQ |
Jun 09, 14:57
Amgen Research and Development Expense (Quarterly) : 1.719B for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 471.10M |
| Gilead Sciences, Inc. | 1.354B |
| Regeneron Pharmaceuticals, Inc. | 1.420B |
| AbbVie, Inc. | 2.472B |
| Viridian Therapeutics, Inc. | 77.51M |